SKORPIOS TRUST
Q4 2021 Form 13-F

LIMASSOL, CYPRUS
CIK 0001869333 · Institutional investment manager
$451.9M Reported Value Total
Reported value
$451.9M
Quarter over quarter
0.0%
Holdings
5
Top-10 concentration
100.0%

Key People

Named on the latest Form 13-F filing — not necessarily an owner
Androulla Papadopoulou
Director

Filing Navigation

13F Metrics

Loading 13F Metrics

Q4 2021 13F record

Q4 2021 13F filing summary

Q4 2021 Form 13F portfolio summary
Period of report December 31, 2021
Filed January 27, 2022
Form 13F-HR
Reported value $451.9M
Positions 5
Change in reported value First reported quarter
Top-10 concentration 100.0%

13F filings by quarter

Form 13F filings by quarter
Quarter Positions Value
Q3 2025 13F
Filed Oct 29, 2025
2 $53.2M
Q2 2025 13F
Filed Jul 30, 2025
2 $37.1M
Q1 2025 13F
Filed May 6, 2025
2 $46.1M
Q4 2024 13F
Filed Feb 5, 2025
2 $76.3M
Q3 2024 13F
Filed Oct 23, 2024
2 $109.6M
Q2 2024 13F
Filed Aug 5, 2024
2 $146.7M
Q1 2024 13F
Filed Apr 26, 2024
2 $195.1M
Q4 2023 13F
Filed Feb 6, 2024
2 $76.1M
Q3 2023 13F
Filed Nov 6, 2023
2 $57.0M
Q2 2023 13F
Filed Aug 3, 2023
4 $230.3M
Q1 2023 13F
Filed May 15, 2023
4 $247.5M
Q4 2022 13F
Filed Feb 7, 2023
4 $314.4M
Q3 2022 13F
Filed Nov 7, 2022
4 $354.3M
Q2 2022 13F
Filed Aug 2, 2022
4 $239.0M
Q1 2022 13F
Filed Apr 22, 2022
4 $375.6M
Q4 2021 13F
Filed Jan 27, 2022
5 $451.9M

Top 5 holdings · Q4 2021

Largest Q4 2021 13F positions by reported value
# Holding Reported value % of portfolio
1 STOK STOKE THERAPEUTICS INC $346.5M 76.67%
2 AKRO AKERO THERAPEUTICS INC $103.8M 22.97%
3 ATVI ACTIVISION BLIZZARD INC $1.4M 0.32%
4 XBI SPDR SER TR $189.0K 0.04%
5 OGN ORGANON & CO $16.0K < 0.01%

Values as reported on the Q4 2021 Form 13F. Every position is in the holdings table below.

Filing Details

Loading Activities
Loading Sector Allocation
Crunching numbers

Potential New Buys

Finding Potential New Buys

Holdings

Building table
Loading SEC filing data
Loading Form 4 Filings

Beneficial Ownership (Schedule 13D/13G)

Loading 13D/G filings